Wastyk et al. (2021) conducted a 10-week randomized controlled trial at Stanford with 36 healthy adults assigned to either a high-fermented-food diet or a high-fiber diet. The fermented food group consumed an average of 6.3 servings per day of fermented foods. Stool samples analyzed by 16S rRNA sequencing showed a significant increase in microbial diversity (measured by Shannon index) in the fermented food group but not in the high-fiber group. The fermented food group also showed decreased levels of 19 inflammatory markers, including IL-6, IL-10, and IL-12b. The authors concluded that fermented foods may be more immediately effective than high-fiber diets at increasing microbial diversity, though both approaches likely have complementary long-term benefits [1].
Marco et al. (2017) reviewed the health benefits of fermented foods and emphasized that the food matrix itself contributes bioactive compounds beyond the live microbes. Fermentation generates peptides, organic acids, and conjugated linoleic acid that have independent anti-inflammatory and metabolic effects. They noted that fermented dairy in particular shows consistent epidemiological associations with reduced cardiovascular disease risk and improved glucose metabolism, effects not fully explained by probiotic content alone. This suggests that the combination of live microbes and their metabolic byproducts in whole fermented foods produces benefits that isolated probiotic strains in capsules may not replicate [2].
Zmora et al. (2018) performed an elegant study in which 25 healthy volunteers consumed an 11-strain probiotic supplement and underwent endoscopy and colonoscopy to directly measure mucosal colonization (rather than relying on stool samples, which poorly reflect mucosal communities). They found that colonization was highly individualized: some participants were "persisters" whose mucosa was readily colonized, while others were "resisters" in whom the probiotics passed through without establishing. Baseline microbiome composition and host gene expression patterns in the gut predicted colonization outcomes. This study challenged the assumption that probiotic supplements universally colonize the gut and highlighted the need for personalized approaches [3].
Suez et al. (2018) followed up on this work by examining microbiome recovery after antibiotic treatment in three groups: spontaneous recovery, probiotic supplementation, or autologous fecal microbiome transplant (aFMT). Counterintuitively, the probiotic group showed significantly delayed reconstitution of their native microbiome (lasting up to 5 months), while the aFMT group recovered within days. The probiotics colonized the antibiotic-emptied gut effectively but then prevented recolonization by the original microbial community. This finding has important clinical implications: routine probiotic use after antibiotics, while potentially reducing acute diarrhea, may have longer-term costs to microbiome recovery that are not captured in short-term clinical trials [4].